Phathom Pharmaceuticals (PHAT) Prepaid Assets (2018 - 2026)

Phathom Pharmaceuticals (PHAT) has 9 years of Prepaid Assets data on file, last reported at $8.4 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $8.4 million, down 35.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.4 million (down 35.39% YoY), and the FY2025 annual result was $15.4 million, down 26.42% from the prior year.
• Prepaid Assets eased to $8.4 million in Q1 2026 per PHAT's latest filing, from $15.4 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $20.9 million in Q4 2024 and troughed at $975000.0 in Q3 2022.
• A 5-year average of $11.2 million and a median of $12.9 million in 2023 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2023 and 2026: Prepaid Assets surged 1226.97% in 2023, then plunged 35.39% in 2026.
• A 5-year view of Prepaid Assets shows it stood at $5.1 million in 2022, then surged by 157.34% to $13.2 million in 2023, then surged by 58.15% to $20.9 million in 2024, then fell by 26.42% to $15.4 million in 2025, then sank by 45.06% to $8.4 million in 2026.
• Business Quant data shows PHAT's Prepaid Assets at $8.4 million in Q1 2026, $15.4 million in Q4 2025, and $13.2 million in Q3 2025.